Results 41 to 50 of about 11,147,283 (241)
Fractalkine (CX3CL1) levels in patients with Behcet's disease and Neuro-Behcet's disease
, 2012 Objective: The aim of the present study was to assess the role of CX3CL1 in patients with active and inactive Behcet's Disease (BD), Neuro-Behcet's Disease (NBD) and control subjects.
Fidan, Işıl +7 more
core +1 more source
Arthritis &Rheumatology, EarlyView.Objective Low copy number (CN) of complement C4 isoforms and high CN of retroviral HERV‐K elements are known risk factors for many immune‐mediated inflammatory diseases (IMIDs), often showing sex‐biased effects. Here, we assessed whether CN variation within the C4 gene contributes to giant cell arteritis (GCA) and IgA vasculitis (IgAV), two complex ...
Laura Martínez‐Gutiérrez +295 more
wiley +1 more source
Increased CD4(+)CD16(+) and CD4(+)CD56(+) T cell subsets in Behcet's disease
, 1999 Behcet's disease is a systemic vasculitis of unknown etiology. Various immune abnormalities have previously been shown in Behcet's disease. We investigated T lymphocyte subsets associated with cytotoxic activity and natural killer (NK) cells by
DİRESKENELİ, RAFİ HANER +1 more
core +1 more source
Rare vasculitis types and obstetric and neonatal outcomes – A population‐based study
International Journal of Gynecology &Obstetrics, EarlyView.Abstract Objective Vasculitis is an infrequent pathology among reproductive‐aged women. While data exists regarding pregnancy outcomes in the more common vasculitis subtypes, data is limited regarding these outcomes in rare vasculitis subtypes. We aimed to compare pregnancy and perinatal outcomes between women who suffered from rare types of vasculitis
Uri Amikam +4 more
wiley +1 more source
Histopathologic study of pathergy test in behçet′s disease
Indian Journal of Dermatology, 2014 Background: The pathergy test (PT) is important in the diagnosis of Behçet′s disease (BD). However, misinterpretation of the test might cause false-positive or false-negative results.
Ekin Ozluk +6 more
doaj +1 more source
Coexistence of ankylosing spondylitis and Behçet's disease: Successful treatment with upadacitinib
Immunity, Inflammation and DiseaseAnkylosing spondylitis (AS) and Behçet's disease (BD) are distinct inflammatory disorders, but their coexistence is a rare clinical entity. This case sheds light on managing this complex scenario with Janus kinase (JAK) inhibitors.
K. Kraev +9 more
semanticscholar +1 more source
Asprosin as a Potential Link Between Vascular Inflammation and Disease Activity in Behçet's Disease
Journal of Clinical Laboratory Analysis, EarlyView.Serum asprosin levels are significantly elevated in patients with Behçet's disease compared to healthy controls. Asprosin concentrations increase progressively with disease activity and are strongly associated with vascular involvement and uveitis, suggesting a potential role as a biomarker of vascular inflammation and disease severity.
Zeynep Kaya +6 more
wiley +1 more source
Experimental Therapeutic Solutions for Behcet’s Disease
Journal of Experimental Pharmacology, 2021 Burçin Cansu Bozca, Erkan Alpsoy Akdeniz University School of Medicine, Department of Dermatology and Venereology, Antalya, TurkeyCorrespondence: Erkan AlpsoyAkdeniz University School of Medicine, Department of Dermatology and Venereology, Antalya,
Bozca BC, Alpsoy E
doaj
HSP 60 expression in mucocutaneous lesions of Behcet's disease
, 2001 Background: Heat shock protein (60 kd HSP) has been implicated in the etiology of Behcet's disease, but its expression at sites of inflammation is unknown. Objective: Our aim was to investigate local HSP 60 expression and to quantify T-cell receptor
DİRESKENELİ, RAFİ HANER +1 more
core +1 more source
Journal of Pediatric Gastroenterology and Nutrition, EarlyView.Abstract Objectives Upper and small bowel Crohn's disease (U‐SBCD) represents a clinically aggressive phenotype with high complication rates yet remains diagnostically challenging. In low‐ and middle‐income countries (LMICs), limited inflammatory bowel disease (IBD) awareness contributes to diagnostic delays, but their impact on U‐SBCD outcomes remains
Jane Oba +12 more
wiley +1 more source